(Q35106477)

6 August 2017

1 reference

title

The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? (English)

1 reference

6 August 2017

1 reference

Toshiaki Kadokami

2

1 reference

6 August 2017

Yoshiro Higuichi

3

1 reference

6 August 2017

Ravi Ramani

4

1 reference

6 August 2017

Arthur M. Feldman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693732

23 December 2023

Charles F. McTiernan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12693732

23 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693732

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S002571250200189X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

https://api.elsevier.com/content/article/PII:S002571250200189X?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

Medical Clinics of North America

23 December 2023

published in

1 reference

6 August 2017

volume

87

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

419-440

1 reference

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Unraveling function in the TNF ligand and receptor families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

The pathophysiology of tumor necrosis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Low-molecular-weight tumor necrosis factor receptor p55 controls induction of autoimmune heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Isolation and characterization of a tumor necrosis factor binding protein from urine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Role for NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

An endotoxin-induced serum factor that causes necrosis of tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor (TNF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cachectin/tumour necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cytokine gene expression in rejecting cardiac allografts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

A controlled trial of anti-tumor necrosis factor alpha antibody for Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Circulating Interleukin-6 in Severe Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Plasma cytokine parameters and mortality in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Direct evidence for cytokine involvement in neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cytokine gene expression after myocardial infarction in rat hearts: possible implication in left ventricular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxide-dependent trypanocidal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor-alpha (TNF-alpha) plays a protective role in acute viralmyocarditis in mice: A study using mice lacking TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Nitric oxide provokes tumor necrosis factor-alpha expression in adult feline myocardium through a cGMP-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cytokine actions of angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Expression of tumor necrosis factor-alpha--converting enzyme and tumor necrosis factor-alpha in human myocarditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Interleukin-1 beta inhibits phospholamban gene expression in cultured cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Mechanism of cytokine inhibition of beta-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes. Impairment of signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Tumor necrosis factor-alpha provokes a hypertrophic growth response in adult cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Matrix metalloproteinases in pathophysiology and treatment of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Inhibition of tumor necrosis factor-alpha and interleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide-stimulated human peripheral blood mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Oxpentifylline in endotoxaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Effects of tumor necrosis factor gene polymorphisms on patients with congestive heart failure. VEST Investigators for TNF Genotype Analysis. Vesnarinone Survival Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

AMPD1 gene mutation in congestive heart failure: new insights into the pathobiology of disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Severe inflammatory arthritis and lymphadenopathy in the absence of TNF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900189-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor

8

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

Tumor necrosis factor induction by Candida albicans from human natural killer cells and monocytes

23 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro

23 December 2023

67

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

Pharmacological modulation of myocardial tumor necrosis factor alpha production by phosphodiesterase inhibitors

23 December 2023

80

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00189-X

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference